Everest Medicines Limited
HKEX:1952.HK
Overview | Financials
Company Name | Everest Medicines Limited |
Symbol | 1952.HK |
Currency | HKD |
Price | 33.3 |
Market Cap | 10,025,256,209 |
Dividend Yield | 0% |
52-week-range | 14.34 - 37.15 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Yongqing Luo |
Website | https://www.everestmedicines.com |
An error occurred while fetching data.
About Everest Medicines Limited
Everest Medicines Limited, a biopharmaceutical company, engages in discovery, licensing, clinical development, and commercialization of therapies to address critical unmet medical needs in Greater China and other Asia Pacific markets. Its pipeline products include eleven clinical-stage drug candidates for the treatment of oncology, immunology, cardio-renal, and infectious diseases. Everest Medicines
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD